TMD & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$345K Hold
2,480
0.24% 31
2019
Q1
$347K Sell
2,480
-36
-1% -$4.82K 0.25% 29
2018
Q4
$325K Buy
2,516
+36
+1% +$5.02K 0.26% 26
2018
Q3
$343K Sell
2,480
-500
-17% -$66.4K 0.24% 22
2018
Q2
$362K Buy
2,980
+523
+21% +$65.2K 0.28% 17
2018
Q1
$315K Buy
2,457
+880
+56% +$119K 0.27% 15
2017
Q4
$220K Sell
1,577
-216
-12% -$30.1K 0.2% 16
2017
Q3
$233K Hold
1,793
0.22% 18
2017
Q2
$237K Sell
1,793
-43
-2% -$5.49K 0.23% 17
2017
Q1
$229K Buy
+1,836
New +$219K 0.21% 21
2016
Q1
Sell
-4,924
Closed -$506K 43
2015
Q4
$506K Buy
+4,924
New +$495K 0.46% 31

Other funds holding JNJ

TMD & Associates's JNJ Position: Q2 2019 in Review

TMD & Associates held its Johnson & Johnson (JNJ) position steady in Q2 2019 at 2,480 shares worth $345K. The position accounts for 0.24% of the portfolio, ranked #31.

TMD & Associates first reported a position in JNJ in Q4 2015 and has held it in 11 quarters since. The position peaked at $506K in Q4 2015. 2,756 funds tracked by Wall St. Rank hold JNJ as of Q2 2019.

  • TMD & Associates held 2,480 shares of Johnson & Johnson worth $345K as of Q2 2019.
  • TMD & Associates left its Johnson & Johnson share count unchanged in Q2 2019.
  • Johnson & Johnson made up 0.24% of TMD & Associates's portfolio in Q2 2019, its #31 holding.
  • TMD & Associates first reported a position in Johnson & Johnson in Q4 2015 and has held it in 11 quarters since.
  • TMD & Associates's Johnson & Johnson position peaked at $506K in Q4 2015.
  • 2,756 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2019.

Based on TMD & Associates's 13F filing for Q2 2019, filed 9 Aug 2019.